Development of Novel ERRalpha Antagonists as Breast Cancer Therapeutics
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Start Date
September 1, 2022
End Date
August 31, 2024
Administered By
Pharmacology & Cancer Biology
Awarded By
National Institutes of Health
Start Date
September 1, 2022
End Date
August 31, 2024